Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09VFU
|
|||
Former ID |
DIB001428
|
|||
Drug Name |
MST-400
|
|||
Synonyms |
MST-400 series; MST-500 series; Integrin-linked kinase inhibitors (cancer); Integrin-linked kinase inhibitors (cancer), MetaSignal
Click to Show/Hide
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
MetaSignal Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Integrin-linked protein kinase 1 (ILK) | Target Info | Inhibitor | [1] |
NetPath Pathway | TCR Signaling Pathway | |||
FSH Signaling Pathway | ||||
Panther Pathway | Integrin signalling pathway | |||
Pathway Interaction Database | Osteopontin-mediated events | |||
Integrin-linked kinase signaling | ||||
Integrins in angiogenesis | ||||
Reactome | Localization of the PINCH-ILK-PARVIN complex to focal adhesions | |||
WikiPathways | Eukaryotic Transcription Initiation | |||
Focal Adhesion | ||||
Primary Focal Segmental Glomerulosclerosis FSGS | ||||
Integrin-mediated Cell Adhesion | ||||
Cell junction organization |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2041). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.